Rozlytrek 100 mg Capsule rigide Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

rozlytrek 100 mg capsule rigide

roche pharma (schweiz) ag - entrectinibum - capsule rigide - entrectinibum 100 mg, lactosum 65 mg, cellulosum microcristallinum, acidum tartaricum, hypromellosum, crospovidonum, magnesii stearas, silica colloidalis anhydrica, kapselhülle: hypromellosum, e 171, e 172 (flavum), drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, e 132, pro capsula. - solide tumoren, nicht-kleinzelliges bronchialkarzinom (nsclc) - synthetika

Rozlytrek 200 mg Capsule rigide Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

rozlytrek 200 mg capsule rigide

roche pharma (schweiz) ag - entrectinibum - capsule rigide - entrectinibum 200 mg, lactosum 130 mg, cellulosum microcristallinum, acidum tartaricum, hypromellosum, crospovidonum, magnesii stearas, silica colloidalis anhydrica, kapselhülle: hypromellosum, e 171, e 110 0.5543 mg, drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, e 132, pro capsula. - solide tumoren, nicht-kleinzelliges bronchialkarzinom (nsclc) - synthetika

Rozlytrek Unione Europea - italiano - EMA (European Medicines Agency)

rozlytrek

roche registration gmbh  - entrectinib - cancer; carcinoma, non-small-cell lung - agenti antineoplastici - rozlytrek as monotherapy is indicated for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (ntrk) gene fusion,who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, andwho have not received a prior ntrk inhibitorwho have no satisfactory treatment options. rozlytrek as monotherapy is indicated for the treatment of adult patients with ros1 positive, advanced non small cell lung cancer (nsclc) not previously treated with ros1 inhibitors.

Sporanox Capsule Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sporanox capsule

janssen-cilag ag - itraconazolum - capsule - itraconazolum 100 mg, hypromellosum, macrogolum 20'000, sacchari sphaerae ut saccharum 175.68 mg et maydis amylum, kapselhülle: gelatina, e 127, e 132, e 171 pro capsula. - antifungini - synthetika

Sporanox G Capsule Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sporanox g capsule

janssen-cilag ag - itraconazolum - capsule - itraconazolum 100 mg, hypromellosum, macrogolum 20'000, sacchari sphaerae ut saccharum 175.68 mg et maydis amylum, kapselhülle: gelatina, e 127, e 132, e 171 pro capsula. - vulvovaginalcandiosis - synthetika

Itraconazol-Mepha 100 Capsule Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

itraconazol-mepha 100 capsule

mepha pharma ag - itraconazolum - capsule - itraconazolum 100 mg, sacchari sphaerae corresp. saccharum max. 179.4 mg, hypromellosum, sorbitani stearas, silica colloidalis hydrica, kapselhülle: gelatina, e 171, e 172 (rubrum), pro capsula. - antifungini - synthetika

Itraconazol axapharm Capsule Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

itraconazol axapharm capsule

axapharm ag - itraconazolum - capsule - kapsel: itraconazolum 100 mg, saccharomonospora, spherae 195 mg, hypromellosum, sorbitani stearas, silice colloidalis hydrica, kapselhülle: gelatina, e-171, e 172 (rubrum), pro capsula. - antifungini - synthetika

Erlotinib Sandoz 25 mg Compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

erlotinib sandoz 25 mg compresse rivestite con film

sandoz pharmaceuticals ag - erlotinibum - compresse rivestite con film - erlotinibum 25 mg ut erlotinibi hydrochloridum, lactosum monohydricum 23.98 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, acidi methacrylici copolymerum a, natrii hydrogenocarbonas, e 171, pro compresso obducto corresp. natrium 0.2 mg. - onkologikum - synthetika

Erlotinib Sandoz 100 mg Compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

erlotinib sandoz 100 mg compresse rivestite con film

sandoz pharmaceuticals ag - erlotinibum - compresse rivestite con film - erlotinibum 100 mg ut erlotinibi hydrochloridum, lactosum monohydricum 95.93 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, acidi methacrylici copolymerum a, natrii hydrogenocarbonas, e 171, pro compresso obducto corresp. natrium 0.7 mg. - onkologikum - synthetika

Erlotinib Sandoz 150 mg Compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

erlotinib sandoz 150 mg compresse rivestite con film

sandoz pharmaceuticals ag - erlotinibum - compresse rivestite con film - erlotinibum 150 mg ut erlotinibi hydrochloridum, lactosum monohydricum 143.9 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, acidi methacrylici copolymerum a, natrii hydrogenocarbonas, e 171, pro compresso obducto corresp. natrium 1.1 mg. - onkologikum - synthetika